Navigation Links
Quick-Core® Biopsy Needles

ProductsQuick-Core® Biopsy Needles
Company Cook Urological
Item Quick-Core® Biopsy Needles
Features 
  • Used to obtain multiple core biopsies of soft tissue.
  • Lightweight and compact, the Quick-Core® Biopsy Needle design facilitates one-handed control.
  • Precise, rapid firing mechanism provides intact core tissue sample.
Description Used to obtain multiple core biopsies of soft tissue. Lightweight and compact, the Quick-Core® Biopsy Needle design facilitates one-handed control. Precise, rapid firing mechanism provides intact core tissue sample. Beveled point stylet permits easy penetration into the specimen with less trauma to surrounding tissue. Sharp cutting edge of cannula helps assure an intact tissue sample. Etched tip enhances visualization during ultrasound imaging. Supplied sterile in peel-open packages. Intended for single patient use only.
Info Cook Urological
Customer Service: (800) 457-4448
Web site: http://www.cookurological.com/

Related medicine products :

1. Madlab Biopsy Forceps
2. Michele Vertebral Biopsy Trephine
3. BIPAL Biopsy Forceps
4. Pointed Biopsy Grasping Forceps
5. MultAcoice™ Biopsy Forceps
6. MultAcoice™ Biopsy Forceps with Teeth
7. Breast Biopsy Guard
8. TargetScan Targeted Prostate Biopsy System
9. Cup Biopsy Forceps
10. Brush Biopsy Sets
11. Deflectable Brush Biopsy Sets
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products:
(Date:12/2/2008)...SCO, Calif., Dec. 1 diaDexus, Inc....l for the automated format of the,PLAC Test for L... capable of,running on a wide range of clinical c...Food & Drug Administration (FDA) in December 2...f the CE Marked PLAC Test to Europe. , The ...
(Date:12/2/2008)...e health differences between groups of immigrants ... are also great. The differences are seen for risk...ew report from the Norwegian Institute of Public H...ompared with each other and the ethnic Norwegian p... target health care better. , The five immigran...
(Date:12/2/2008)... 2 Smile Reminder, the nation,s le..., unveiled the latest in industry,technology toda...igital tool,for capturing and distributing video ...atient testimonials onto popular platforms such as...w tool provides doctors with an effective,busines...
(Date:12/2/2008)...for Tuesday, December 2, 2008 at 3 pm CST)--Radiol...l University of South Carolina in Charleston, S.C....ncer from exposure to radiation during computed to...tated and that new estimates are several times low...C researchers presented their findings at the ann...
Breaking Medicine News(10 mins):Health News:diaDexus Receives CE Mark Certification for the PLAC(R) Test 2Health News:Large health differences between population groups in Norway 2Health News:Large health differences between population groups in Norway 3Health News:Large health differences between population groups in Norway 4Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2
...cancer is the fourth leading cause of cancer death...o are usually affected // It is one of the most d...n until it has spread to other parts. Only about f...cancer patients survive the first five years after...
... comes in the way of the physical and mental growt...Tuesday stressing// on the need to "protect, prese...ting the first Global Youth Meet on Health in the ...lso a fundamental human right. While every citizen...
...e remedy of choice for treatment of influenza is c...ports of psychiatric// side effects, regulators s... change after series of cases of self-injury and m...y people who had been taking this drug Unfortunat...
...article published in the Lancet has brought to lig...blems for the Indian //community. With only 2.2per...he category of obese this clearly shows that the I.... It is estimated that 12 percent of the adult po...
Other Medicine News:Health News:PM Stress the Need to Protect Health of Children 2Health News:Caution:Tamiflu ‘tames’ flu but psychiatric side effects now report 2
(Date:12/2/2008)...A, Kan., Dec. 2 IBT Laboratories, ...earch laboratory specializing in immunology and al...tests to evaluate the response of patients whose ... immunodeficiency disorder, chemotherapy drugs, or...to prevent rejection of a transplant. The company ...
(Date:12/1/2008)... , , CHICAGO, Dec. 2 /PRNewswire-USNewswir...mography (PEM), a new technique for imaging the br...a woman,s hormonal status, two factors that limit ...at detecting cancer. Results will be presented tod...ty of North America (RSNA). , , "The abili...
(Date:12/1/2008)...Girl with Hypophosphatasia Treated With ENB-0040 a...innipeg , , MONTREAL, Dec. 1 /PRNewswire/ -...any focused on developing novel therapeutics for s...rst infant patient in its clinical program for hyp...nzyme Replacement Therapy (ERT) with ENB-0040 for ...
(Date:12/1/2008)...nference Call Scheduled for Tuesday, December 9 at...ML -- , , SOUTH SAN FRANCISCO, Calif., Dec...icals, Inc. (Nasdaq: SNSS ), a biopharmaceutical...ization of new oncology therapeutics, today announ...e myeloid leukemia (AML) will be presented during ...
Breaking Medicine Technology:IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Spheris Reports Third Quarter 2008 Results 29706 1Spheris Reports Third Quarter 2008 Results 29706 2Spheris Reports Third Quarter 2008 Results 29706 3Spheris Reports Third Quarter 2008 Results 29706 4Spheris Reports Third Quarter 2008 Results 29706 5Spheris Reports Third Quarter 2008 Results 29706 6Spheris Reports Third Quarter 2008 Results 29706 7Spheris Reports Third Quarter 2008 Results 29706 8Spheris Reports Third Quarter 2008 Results 29706 9Spheris Reports Third Quarter 2008 Results 29706 10Spheris Reports Third Quarter 2008 Results 29706 11MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results 29704 1MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results 29704 2MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results 29704 3MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results 29704 4MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results 29704 5MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results 29704 6Porter Novelli Named Agency of Record for Pharmavite 28R 29 LLC 29702 1Porter Novelli Named Agency of Record for Pharmavite 28R 29 LLC 29702 2Imagenetix Inc Reports Second Quarter and Six Month Results 9160 1Imagenetix Inc Reports Second Quarter and Six Month Results 9160 2Imagenetix Inc Reports Second Quarter and Six Month Results 9160 3Imagenetix Inc Reports Second Quarter and Six Month Results 9160 4
...e/ -- D-Pharm announced,today that the results of ...nd DP-b99 in the treatment of acute ischemic,strok...e,Conference. The data will be presented by the st...ener, on Thursday May 31st at,14.30 in the Carron ... in Glasgow. The abstract for the presentation may...
...on three investigational,agents (VEGF Trap, S-1 an...ASCO meeting, BRIDGEWATER, N.J., May 29, 2007 /PRN...ay that a total of 375 abstracts,indicative of its...rd Annual Meeting of the American Society of Clini..., 2007). The results from key,studies involving th...
Other Medicine Technology:DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 2DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 3Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 2Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 3Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 4Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 5Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 6Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 7Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 8Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 9Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 10Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 11Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 12